Atlas Trials

Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty

Clinical trial NCT02525133 · COMPLETED

Trial details

NCT number
NCT02525133
Sponsor
Innocoll
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pain, Postoperative
Start date
2015-09-05
Primary completion
2016-04-22
Enrollment
319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.